Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Interest Coverage N/A
UPI's Interest Coverage is ranked lower than
99.99% of the 223 Companies
in the Global Medical Devices industry.

( Industry Median: 69.16 vs. UPI: N/A )
Ranked among companies with meaningful Interest Coverage only.
UPI' s Interest Coverage Range Over the Past 10 Years
Min: 0  Med: 0 Max: N/A
Current: N/A
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 2/10

vs
industry
vs
history
» UPI's 10-Y Financials

Financials (Next Earnings Date: 0)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q3 2014

UPI Guru Trades in Q3 2014

Jim Simons 131,033 sh (+6.38%)
» More
Q4 2014

UPI Guru Trades in Q4 2014

Jim Simons 142,300 sh (+8.60%)
» More
Q1 2015

UPI Guru Trades in Q1 2015

Jim Simons 289,600 sh (+103.51%)
» More
Q2 2015

UPI Guru Trades in Q2 2015

Jim Simons Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with UPI

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices
Compare:NAS:CGNT, OTCPK:ZMSPF, OTCPK:BSGM, NAS:MGCD, OTCPK:VASO, OTCPK:AMDHF, NAS:EVAR, OTCPK:IGNG, OTCPK:TLTFF, AMEX:XTNT, OTCPK:MRICD, NAS:SSH, AMEX:ELMD, NAS:NVCN, NAS:AMDA, OTCBB:NAOV, NAS:MDVX, OTCPK:DTXMF, OTCPK:CRVW, OTCPK:DIZTF » details


Uroplasty Inc was incorporated on January 21, 1992 as a Minnesota corporation. It is a medical device company. It develops, manufactures and markets innovative, proprietary products for the treatment of voiding dysfunctions. Its primary focus is on two products: the Urgent PC Neuromodulation System, and Macroplastique Implants. The Urgent PC Neuromodulation System delivers percutaneous tibial nerve stimulation for office-based treatment of overactive bladder and the associated symptoms of urinary urgency, urinary frequency, and urge incontinence. The Macroplastique Implants is an injectable, urethral bulking agent for the treatment of adult female stress urinary incontinence primarily due to intrinsic sphincter deficiency. The Company is focusing its sales and marketing efforts primarily on urologists, urogynecologists and gynecologists with significant office-based and outpatient surgery-based patient volume. The testing, manufacturing, promotion, marketing and distribution of the Company's products in the United States, Europe and other parts of the world are subject to regulation by numerous governmental authorities, including the FDA, the European Union and other analogous agencies.

Ratios

vs
industry
vs
history

Buy Back

vs
industry
vs
history

Valuation & Return

vs
industry
vs
history

More Statistics

Revenue (TTM) (Mil) $25.87
EPS (TTM) $ -0.30
Short Percentage of Float0.49%
52-Week Range $1.05 - 4.05
Shares Outstanding (Mil)22.15

Analyst Estimate


Warning: Invalid argument supplied for foreach() in /home/gurufocu/public_html/modules/stock/estimate.php on line 163
Mar15 Mar16
Revenue (Mil $) 27 29
EPS ($) -0.26 -0.15
EPS w/o NRI ($) -0.26 -0.15
EPS Growth Rate
(3Y to 5Y Estimate)
15.00%
Dividends Per Share ($)

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)